Homeostatic interferon expression in neurons is sufficient for early control of viral infection

Journal of Neuroimmunology

Volumn 279, Issue C, 2015, Pages 11-19

  Cavanaugh, Sarah E ^a,b   Holmgren, Alicia M ^a,b   Rall, Glenn F ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Interferon; Neuron; Signaling; Stat1; Stat2

Indexed keywords

BETA INTERFERON; INTERFERON; STAT1 PROTEIN; STAT2 PROTEIN; TYPE 1 INTERFERON; UNCLASSIFIED DRUG; 2',5' OLIGOADENYLATE SYNTHETASE; CYTOKINE; ENOLASE; G1P2 PROTEIN, MOUSE; MEMBRANE COFACTOR PROTEIN; MESSENGER RNA; UBIQUITIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; EMBRYO; EMBRYO CELL; FIBROBLAST; GENE EXPRESSION; HIPPOCAMPAL NEURONAL CULTURE; HIPPOCAMPUS; HOMEOSTASIS; INFECTION CONTROL; KINETICS; MOUSE; NERVE CELL; NERVE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRUS INFECTION; ANIMAL; CELL CULTURE; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; GENETICS; MAMMALIAN EMBRYO; MEASLES; MEASLES VIRUS; METABOLISM; PATHOGENICITY; PATHOLOGY; TIME FACTOR; TRANSGENIC MOUSE; VIROLOGY;

2',5'-OLIGOADENYLATE SYNTHETASE; ANIMALS; ANTIGENS, CD46; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; EMBRYO, MAMMALIAN; FIBROBLASTS; HIPPOCAMPUS; INTERFERONS; MEASLES; MEASLES VIRUS; MICE; MICE, TRANSGENIC; NEURONS; PHOSPHOPYRUVATE HYDRATASE; RNA, MESSENGER; STAT1 TRANSCRIPTION FACTOR; STAT2 TRANSCRIPTION FACTOR; TIME FACTORS; UBIQUITINS;

EID: 84927513303     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2014.12.012     Document Type: Article

References (51)

1. Banker G., Goslin K. Culturing Nerve Cells 1991, MIT Press, Cambridge.
2. Binder G.K., Griffin D.E. Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons. Science 2001, 293(5528):303-306.
3. Brzozka K., Finke S., Conzelmann K.K. Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J. Virol. 2005, 79(12):7673-7681.
4. Campbell D.S., Holt C.E. Chemotropic responses of retinal growth cones mediated by rapid local protein synthesis and degradation. Neuron 2001, 32(6):1013-1026.
5. Carr D.J., et al. RNA-dependent protein kinase is required for alpha-1 interferon transgene-induced resistance to genital herpes simplex virus type 2. J. Virol. 2005, 79(14):9341-9345.
6. Curtsinger J.M., et al. Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol. 2005, 174(8):4465-4469.
7. Detje C.N., et al. Local type I IFN receptor signaling protects against virus spread within the central nervous system. J. Immunol. 2009, 182(4):2297-2304.
8. Dorries R. The role of T-cell-mediated mechanisms in virus infections of the nervous system. Curr. Top. Microbiol. Immunol. 2001, 253:219-245.
9. Dubois-Dalcq M., Coblentz J.M., Pleet A.B. Subacute sclerosing panencephalitis. Unusual nuclear inclusions and lengthy clinical course. Arch. Neurol. 1974, 31(6):355-363.
10. Eberwine J., et al. Analysis of subcellularly localized mRNAs using in situ hybridization, mRNA amplification, and expression profiling. Neurochem. Res. 2002, 27(10):1065-1077.
11. Fensterl V., et al. Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis. PLoS Pathog. 2012, 8(5):e1002712.
12. Fritz-French C., Tyor W. Interferon-alpha (IFNalpha) neurotoxicity. Cytokine Growth Factor Rev. 2012, 23(1-2):7-14.
13. Griffin D.E., Metcalf T. Clearance of virus infection from the CNS. Curr. Opin. Virol. 2011, 1(3):216-221.
14. Hashioka S., et al. Stat3 inhibitors attenuate interferon-gamma-induced neurotoxicity and inflammatory molecule production by human astrocytes. Neurobiol. Dis. 2011, 41(2):299-307.
15. Hibbert L., et al. IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells. J. Interferon Cytokine Res. 2003, 23(9):513-522.
16. Horisberger M.A., Haller O., Arnheiter H. Interferon-dependent genetic resistance to influenza virus in mice: virus replication in macrophages is inhibited at an early step. J. Gen. Virol. 1980, 50(1):205-210.
17. Ida-Hosonuma M., et al. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J. Virol. 2005, 79(7):4460-4469.
18. James S.H., Kimberlin D.W., Whitley R.J. Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection. Antivir. Res. 2009, 83(3):207-213.
19. Johnson R.T. Viral Infections of the Nervous System 1998, Lippincott-Raven, Philadelphia.
20. Kalinke U., Prinz M. Endogenous, or therapeutically induced, type I interferon responses differentially modulate Th1/Th17-mediated autoimmunity in the CNS. Immunol. Cell Biol. 2012, 90(5):505-509.
21. Kieseier B.C. The mechanism of action of interferon-beta in relapsing multiple sclerosis. CNS Drugs 2011, 25(6):491-502.
22. Kleiman R., Banker G., Steward O. Differential subcellular localization of particular mRNAs in hippocampal neurons in culture. Neuron 1990, 5(6):821-830.
23. Kundig T.M., Hengartner H., Zinkernagel R.M. T cell-dependent IFN-gamma exerts an antiviral effect in the central nervous system but not in peripheral solid organs. J. Immunol. 1993, 150(6):2316-2321.
24. Mehla R., et al. Programming of neurotoxic cofactor CXCL-10 in HIV-1-associated dementia: abrogation of CXCL-10-induced neuro-glial toxicity in vitro by PKC activator. J. Neuroinflammation 2012, 9(1):239.
25. Mizuno T., et al. Interferon-gamma directly induces neurotoxicity through a neuron specific, calcium-permeable complex of IFN-gamma receptor and AMPA GluR1 receptor. FASEB J. 2008, 22(6):1797-1806.
26. Mrkic B., et al. Measles virus spread and pathogenesis in genetically modified mice. J. Virol. 1998, 72(9):7420-7427.
27. Muller U., et al. Functional role of type I and type II interferons in antiviral defense. Science 1994, 264(5167):1918-1921.
28. Nishikomori R., et al. Activated Stat4 has an essential role in Th1 differentiation and proliferation that is independent of its role in the maintenance of IL-12R beta 2 chain expression and signaling. J. Immunol. 2002, 169(8):4388-4398.
29. Pasick J.M., Kalicharran K., Dales S. Distribution and trafficking of JHM coronavirus structural proteins and virions in primary neurons and the OBL-21 neuronal cell line. J. Virol. 1994, 68(5):2915-2928.
30. Patten S.B. Psychiatric side effects of interferon treatment. Curr. Drug Saf. 2006, 1(2):143-150.
31. Patterson C.E., et al. Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma interferon dependent. J. Virol. 2002, 76(9):4497-4506.
32. Poon M.M., et al. Identification of process-localized mRNAs from cultured rodent hippocampal neurons. J. Neurosci. 2006, 26(51):13390-13399.
33. Qing Y., Stark G.R. Alternative activation of Stat1 and Stat3 in response to interferon-gamma. J. Biol. Chem. 2004, 279(40):41679-41685.
34. Radaeva S., et al. Interferon-alpha activates multiple Stat signals and down-regulates c-Met in primary human hepatocytes. Gastroenterology 2002, 122(4):1020-1034.
35. Rall G.F., Mucke L., Oldstone M.B. Consequences of cytotoxic T lymphocyte interaction with major histocompatibility complex class I-expressing neurons in vivo. J. Exp. Med. 1995, 182(5):1201-1212.
36. Rall G.F., et al. A transgenic mouse model for measles virus infection of the brain. Proc. Natl. Acad. Sci. U. S. A. 1997, 94(9):4659-4663.
37. Ramana C.V., et al. Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling. Trends Immunol. 2002, 23(2):96-101.
38. Rodgers B.C., Mims C.A. Role of macrophage activation and interferon in the resistance of alveolar macrophages from infected mice to influenza virus. Infect. Immun. 1982, 36(3):1154-1159.
39. Rose R.W., et al. Altered levels of Stat1 and Stat3 influence the neuronal response to interferon gamma. J. Neuroimmunol. 2007, 192(1-2):145-156.
40. Sakamoto S., et al. Cells previously desensitized to type 1 interferons display different mechanisms of activation of stat-dependent gene expression from naive cells. J. Biol. Chem. 2004, 279(5):3245-3253.
41. Samuel M.A., Diamond M.S. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J. Virol. 2005, 79(21):13350-13361.
42. Sas A.R., et al. Interferon-alpha causes neuronal dysfunction in encephalitis. J. Neurosci. 2009, 29(12):3948-3955.
43. Schoggins J.W., Rice C.M. Interferon-stimulated genes and their antiviral effector functions. Curr. Opin. Virol. 2011, 1(6):519-525.
44. Smith J.A., et al. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res. Bull. 2012, 87(1):10-20.
45. Soike K.F., Kramer M.J., Gerone P.J. In vivo antiviral activity of recombinant type alpha interferon A in monkeys with infections due to simian varicella virus. J. Infect. Dis. 1983, 147(5):933-938.
46. Stark G.R., et al. How cells respond to interferons. Annu. Rev. Biochem. 1998, 67:227-264.
47. Studahl M. Influenza virus and CNS manifestations. J. Clin. Virol. 2003, 28(3):225-232.
48. Surace M.J., Block M.L. Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors. Cell. Mol. Life Sci. 2012, 69(14):2409-2427.
49. von Boxel-Dezaire A.H., Rani M.R., Stark G.R. Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 2006, 25(3):361-372.
50. Wilms H., et al. Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications. Curr. Pharm. Des. 2007, 13(18):1925-1928.
51. Zurney J., Howard K.E., Sherry B. Basal expression levels of IFNar and Jak-Stat components are determinants of cell-type-specific differences in cardiac antiviral responses. J. Virol. 2007, 81(24):13668-13680.